Lv1
30 积分 2025-03-16 加入
T cell-targeted antibody reverses fibrosis
9小时前
已完结
Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database
4个月前
已完结
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study
4个月前
已完结
Chitinase 3–Like 1 Promotes Endothelial‐to‐Mesenchymal Transition in Systemic Sclerosis via Mechanistic Target of Rapamycin Complex 1 Signaling Pathway
8个月前
已完结
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease
8个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
8个月前
已完结
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study
8个月前
已完结
T-cell-engaging bispecific antibodies in cancer
8个月前
已完结
Spatially informed phenotyping by cyclic-in-situ-hybridisation identifies novel fibroblast populations and their pathogenic niches in systemic sclerosis
8个月前
已完结
Spatial multiomics decipher fibroblast–macrophage dynamics in systemic sclerosis
8个月前
已完结
皖公网安备34019202002308
